| abstract |
Oral administration formulations with improved palatability of the present invention are excellent in palatability of canine animals, facilitate long-term oral administration, and improve blood circulation. In addition, when used in combination with a heart disease drug, it can be applied as a drug for treating bicuspid valve degeneration in canine animals or for symptomatic relief. |